tiprankstipranks
Accelerate Diagnostics (AXDX)
NASDAQ:AXDX
US Market

Accelerate Diagnostics (AXDX) Income Statement

Compare
300 Followers

Accelerate Diagnostics Income Statement

Last quarter (Q4 2024), Accelerate Diagnostics's total revenue was $2.82M, a decrease of -6.13% from the same quarter last year. In Q4, Accelerate Diagnostics's net income was $-9.59M. See Accelerate Diagnostics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 11.70M$ 12.06M$ 12.75M$ 11.78M$ 11.16M
Gross Profit
$ 2.70M$ 2.55M$ 3.30M$ -381.00K$ 4.46M
Operating Expenses
$ 38.01M$ 56.58M$ 66.11M$ 71.18M$ 68.16M
Depreciation and Amortization
$ 3.42M$ 3.25M$ 3.00M$ 2.52M$ 3.00M
EBITDA
$ -33.57M$ -49.77M$ -55.80M$ -59.59M$ -59.66M
Operating Income
$ -35.31M$ -54.03M$ -62.80M$ -71.56M$ -63.70M
Other Income/Expenses
$ -14.80M$ -6.74M$ 235.00K$ -6.10M$ -14.50M
Pretax Income
$ -50.11M$ -60.77M$ -62.57M$ -77.66M$ -78.20M
Net Income
$ -50.05M$ -61.62M$ -62.49M$ -77.70M$ -78.21M
Per Share Metrics
Basic EPS
$ -2.15$ -4.94$ -7.61$ -12.59$ -13.96
Diluted EPS
$ -2.15$ -4.94$ -7.61$ -12.59$ -13.96
Weighted Average Shares Outstanding
23.30M 12.48M 8.22M 6.17M 5.60M
Weighted Average Shares Outstanding (Diluted)
23.30M 12.48M 8.22M 6.17M 5.60M
Currency in USD

Accelerate Diagnostics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis